Insider Transactions in Q2 2022 at Vaxcyte, Inc. (PCVX)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 28
2022
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect |
10,000
-2.81%
|
$210,000
$21.0 P/Share
|
Jun 24
2022
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
747
-0.11%
|
$15,687
$21.01 P/Share
|
Jun 23
2022
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
3,541
-0.51%
|
$74,361
$21.01 P/Share
|
Jun 22
2022
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,261
-0.18%
|
$26,481
$21.01 P/Share
|
Jun 21
2022
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,451
-0.77%
|
$114,471
$21.05 P/Share
|
Jun 07
2022
|
Mikhail Eydelman SVP, GEN COUNSEL & CORP SEC |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+50.0%
|
-
|
Jun 01
2022
|
Halley E Gilbert Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,125
+50.0%
|
-
|
Jun 01
2022
|
Peter Hirth Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,125
+50.0%
|
-
|
Jun 01
2022
|
Heath Lukatch Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,125
+50.0%
|
-
|
Jun 01
2022
|
Anne S Drapeau Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,125
+50.0%
|
-
|
Jun 01
2022
|
Teri Loxam Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,125
+50.0%
|
-
|
Jun 01
2022
|
Michael E. Kamarck Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,125
+50.0%
|
-
|
Jun 01
2022
|
Carlos V Paya Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,125
+50.0%
|
-
|
May 23
2022
|
Paul Sauer SVP Process Dev, Manufacturing |
SELL
Open market or private sale
|
Direct |
3,000
-11.24%
|
$78,000
$26.22 P/Share
|
May 20
2022
|
Jeff Fairman VP, Research |
SELL
Open market or private sale
|
Indirect |
4,112
-1.26%
|
$102,800
$25.5 P/Share
|
May 18
2022
|
Andrew Guggenhime PRESIDENT AND CFO |
SELL
Open market or private sale
|
Direct |
3,100
-3.46%
|
$74,400
$24.74 P/Share
|
May 18
2022
|
Andrew Guggenhime PRESIDENT AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,100
+6.41%
|
$15,500
$5.35 P/Share
|
May 16
2022
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
11,000
-0.77%
|
$264,000
$24.02 P/Share
|
May 16
2022
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+1.52%
|
$11,000
$1.79 P/Share
|
May 05
2022
|
Jeff Fairman VP, Research |
SELL
Open market or private sale
|
Indirect |
888
-0.27%
|
$22,200
$25.8 P/Share
|
Apr 22
2022
|
Paul Sauer SVP Process Dev, Manufacturing |
SELL
Open market or private sale
|
Direct |
3,000
-10.67%
|
$75,000
$25.0 P/Share
|
Apr 18
2022
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
11,000
-1.54%
|
$253,000
$23.98 P/Share
|
Apr 18
2022
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+1.52%
|
$11,000
$1.79 P/Share
|
Apr 18
2022
|
Andrew Guggenhime PRESIDENT AND CFO |
SELL
Open market or private sale
|
Direct |
3,100
-7.09%
|
$74,400
$24.05 P/Share
|
Apr 18
2022
|
Andrew Guggenhime PRESIDENT AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,100
+6.62%
|
$15,500
$5.35 P/Share
|
Apr 18
2022
|
Jim Wassil CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,800
-6.12%
|
$64,400
$23.98 P/Share
|
Apr 18
2022
|
Jim Wassil CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,800
+5.77%
|
$5,600
$2.42 P/Share
|
Apr 05
2022
|
Jeff Fairman VP, Research |
SELL
Open market or private sale
|
Indirect |
5,000
-1.51%
|
$125,000
$25.59 P/Share
|